Top Pharma Recruiters Advertising in December 2022
Published on:
6 Dec 2022
Category:
Latest articles
-
About Vectura
-
Voydeya approved in the EU as add-on treatment to ravulizumab or eculizumab for adults with the rare disease PNH who have residual haemolytic anaemia
-
Vertex and TreeFrog Therapeutics Announce Licensing Agreement and Collaboration to Optimize Production of Vertex’s Cell Therapies for Type 1 Diabetes